Hsbc Holdings PLC Grows Holdings in National Health Investors, Inc. $NHI

Hsbc Holdings PLC raised its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 10.5% in the 2nd quarter, Holdings Channel reports. The firm owned 93,376 shares of the real estate investment trust’s stock after purchasing an additional 8,856 shares during the quarter. Hsbc Holdings PLC’s holdings in National Health Investors were worth $7,121,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of National Health Investors in the second quarter worth about $665,997,000. Bank of New York Mellon Corp bought a new stake in National Health Investors during the 2nd quarter valued at about $122,509,000. Bank of America Corp DE bought a new stake in National Health Investors during the 2nd quarter valued at about $77,738,000. Norges Bank purchased a new stake in National Health Investors in the 4th quarter valued at about $55,301,000. Finally, Freestone Grove Partners LP purchased a new stake in National Health Investors in the 4th quarter valued at about $21,869,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Down 1.8%

NYSE NHI opened at $70.11 on Thursday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The company has a market capitalization of $3.44 billion, a price-to-earnings ratio of 20.26, a price-to-earnings-growth ratio of 3.81 and a beta of 0.52. The company’s 50-day simple moving average is $75.02 and its two-hundred day simple moving average is $77.73. National Health Investors, Inc. has a one year low of $67.94 and a one year high of $91.38.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million during the quarter. During the same period in the previous year, the company posted $1.22 EPS. National Health Investors’s revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts forecast that National Health Investors, Inc. will post 4.76 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. National Health Investors’s dividend payout ratio is currently 106.36%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on NHI. Wells Fargo & Company reduced their target price on shares of National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Tuesday, September 1st. Truist Financial dropped their price objective on National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, September 2nd. Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. National Bank Financial set a $79.00 target price on National Health Investors in a research report on Wednesday. Finally, Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, National Health Investors presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.71.

Insider Transactions at National Health Investors

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 2.70% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.